PAI Partners Acquires Majority Stake in Nutripure

PAI Partners Agrees to Acquire Majority Stake in ECF Group

June 14, 2023

Logistics & Distribution

PAI Partners has made a binding offer to acquire a majority stake in ECF Group from French private equity firm Naxicap Partners, with Naxicap remaining a minority investor alongside management. ECF is an omnichannel B2B distributor of equipment, consumables and hygiene products for hospitality and care professionals, headquartered in Grigny, France (~1,750 employees, ~€760m revenue); PAI intends to accelerate growth organically and via acquisitions to consolidate the fragmented market.

PAI Partners Acquires Majority Stake in Uvesco

December 22, 2021

Retail

PAI Partners, via its PAI Mid-Market Fund, has signed an agreement to acquire a majority stake in Uvesco from the company’s current shareholders. The investment will support Uvesco’s organic store rollout and M&A-driven expansion across Northern Spain and Madrid while keeping the company headquartered in Guipúzcoa.

PAI Partners to Acquire Majority Stake in Infra Group

July 6, 2023

Infrastructure

PAI Partners has agreed to acquire a majority stake in Infra Group, a Belgium-headquartered multi-disciplinary network infrastructure services provider. The investment will make PAI the largest shareholder alongside existing investors ICG, Andera Partners and the management team, and will support Infra Group's growth strategy to accelerate expansion organically and via complementary acquisitions.

Vision Healthcare Acquires AixSwiss (Nupure)

September 23, 2022

Consumer Products

Vision Healthcare has acquired 100% of AixSwiss BV, the Dutch owner of the fast-growing probiotic nutraceutical brand Nupure, which generated approximately €20m in sales in 2022. The deal strengthens Vision Healthcare’s pan‑European digital omni‑channel VMS and nutraceutical platform and adds probiotic product capability and DACH e‑commerce reach to its portfolio.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

PAI Partners to acquire Nuzoa from Abac Capital

March 24, 2025

Veterinary

PAI Partners, via its PAI Mid-Market Fund, has agreed to acquire Nuzoa, the leading integrated animal health products and services distributor in Iberia, from Abac Capital. PAI plans to accelerate Nuzoa's growth through further consolidation in the fragmented Iberian market, expansion into other European markets and by developing additional vet-focused services such as digital solutions and laboratory diagnostics.